8,548 Shares in VanEck Pharmaceutical ETF $PPH Bought by Peak Planning Group LLC

Peak Planning Group LLC purchased a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,548 shares of the company’s stock, valued at approximately $882,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AlphaCore Capital LLC purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter worth $31,000. Group One Trading LLC purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter worth $36,000. IFP Advisors Inc grew its stake in VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after purchasing an additional 153 shares during the period. Advisory Services Network LLC purchased a new stake in VanEck Pharmaceutical ETF in the third quarter worth $41,000. Finally, REAP Financial Group LLC purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter worth $52,000.

VanEck Pharmaceutical ETF Trading Down 0.7%

VanEck Pharmaceutical ETF stock opened at $106.47 on Friday. The business’s fifty day simple moving average is $103.01 and its two-hundred day simple moving average is $104.35. VanEck Pharmaceutical ETF has a 12 month low of $81.74 and a 12 month high of $112.58. The company has a market capitalization of $1.01 billion, a price-to-earnings ratio of 20.21 and a beta of 0.47.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Wednesday, April 1st were issued a $0.8441 dividend. This represents a $3.38 annualized dividend and a yield of 3.2%. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. The ex-dividend date of this dividend was Wednesday, April 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.